Division of Nephrology and Immunology, RWTH University of Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany.
Nat Rev Nephrol. 2011 Apr;7(4):237-41. doi: 10.1038/nrneph.2010.169. Epub 2010 Dec 14.
A 47-year-old man with a 6-year history of chronic dialysis for end-stage renal disease of unknown etiology presented for renal transplantation. While on dialysis, he had developed secondary hyperparathyroidism, which persisted after transplantation despite treatment with cinacalcet.
Physical examination, serum and urine analysis, ultrasound of the renal transplant, renal biopsy, bone scintigraphy.
Severe persistent hyperparathyroidism associated with mild hypercalcemia following renal transplantation. Initiation of a calcimimetic followed by fulminant graft failure. Extensive tubular calcinosis.
Renal transplantation (with immunosuppressant medications: basiliximab, tacrolimus, mycophenolate mofetil, prednisolone), cinacalcet (halted on day 26 after transplantation), angiotensinconverting-enzyme inhibitor, angiotensin-receptor blocker, hydrochlorothiazide, emergency dialysis, subtotal parathyroidectomy.
一名 47 岁男性,因病因不明的终末期肾病接受慢性透析治疗已有 6 年,现因肾衰竭接受肾移植。在透析期间,他出现了继发性甲状旁腺功能亢进,尽管使用西那卡塞治疗,但在移植后仍持续存在。
体格检查、血清和尿液分析、肾移植超声、肾活检、骨闪烁扫描。
肾移植后严重持续甲状旁腺功能亢进伴轻度高钙血症。钙敏感受体激动剂治疗后,迅速发生移植物衰竭。广泛的肾小管钙化。
肾移植(免疫抑制剂药物:巴利昔单抗、他克莫司、霉酚酸酯、泼尼松龙),西那卡塞(移植后第 26 天停用),血管紧张素转换酶抑制剂,血管紧张素受体阻滞剂,氢氯噻嗪,紧急透析,甲状旁腺次全切除术。